Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Dicpinigaitis P. New developments in the treatment and management of chronic cough: managed care considerations on the role of new and emerging therapie. J Manag Care Med. 2022;25(4):16-19.
2. Dicpinigaitis P. Understanding the foundations of chronic cough. Am J Manag Care. 2020;26(11 Suppl):S232-S238.
3. McGarvey L, Gibson PG. What is chronic cough? Terminology. J Allergy Clin Immunol Pract. 2019;7(6):1711-1714.
4. Hull JH, Langerman H, Ul-Haq Z, Kamalati T, Lucas A, Levy ML. Burden and impact of chronic cough in UK primary care: a data-set analysis. BMJ Open. 2021;11(12):e054832.
5. Parker SM, Smith JA, Birring SS, et al. British Thoracic Society clinical statement on chronic cough in adults. Thorax. 2023;78(Suppl 6):s3-s19.
6. Irwin RS, Oppenheimer JJ, Dunlap W, Lieberman JA, Chang AB. Yardstick for managing cough, part 1: in adults and adolescent patients older than 14 years of age. Ann Allergy Asthma Immunol. 2023;130(3):379-391.
7. Song WJ, Morice AH. Cough hypersensitivity syndrome: a few more steps forward. Allergy Asthma Immunol Res. 2017;9(5):394-402.
9. Morice AH, Millqvist E, Belvisi MG, et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014;44(5):1132-1148.
10. Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136.
11. Kardos P, Dinh QT, Fuchs K-H, et al. German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough. Respir Med. 2020:170:105939.
12. Guilleminault L, Demoulin-Alexikova S, de Gabory L, et al. Guidelines for the management of chronic cough in adults. Endorsed by the French speaking society of respiratory diseases (Société de Pneumologie de Langue Française, SPLF), the Société Française d'Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou (SFORL), the Société Française de Phoniatrie et de Laryngologie (SFPL), the Société Nationale Française de Gastro-entérologie (SNFGE). Respir Med Res. 2023:83:101011.
13. Joo H, Moon J-Y, An TJ, et al. Revised Korean cough guidelines, 2020: recommendations and summary statements. Tuberc Respir Dis (Seoul). 2021;84(4):263-273.
14. Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410-419.
15. Lee J-H, Lee J-H, Park S-Y, Koskela HO, Song WJ. Is fractional exhaled nitric oxide a treatable trait in chronic cough: a narrative review. J Thorac Dis. 2023;15(10):5844-5855.
16. McDonald VM, Gibson PG. Treatable traits in asthma: moving beyond diagnostic labels. Med J Aust. 2022;216(7):331-333.
17. Agusti A, Gibson PG, McDonald VM. Treatable traits in airway disease: from theory to practice. J Allergy Clin Immunol Pract. 2023;11(3):713-723.
18. Song W-J, Dupont L, Birring SS, et al. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study. ERJ Open Res. 2023;9(6):00618-2023.
19. Chung KF, McGarvey L, Song W-J, et al. Cough hypersensitivity and chronic cough. Nat Rev Dis Primers. 2022;8(1):45.
20. Rouadi PW, Idriss SA, Bousquet J, et al. WAO-ARIA consensus on chronic cough. Part II: phenotypes and mechanisms of abnormal cough presentation: updates in COVID-19. World Allergy Organ J. 2021;14(12):100618.
21. Driessen AK, Devlin A-C, Lundy FT, et al. Perspectives on neuroinflammation contributing to chronic cough. Eur Respir J. 2020;56(4):2000758.
22. Chung KF, McGarvey L, Mazzone SB. Chronic cough as a neuropathic disorder. Lancet Respir Med. 2013;1(5):414-422.
23. Sykes DL, Zhang M, Morice AH. Treatment of chronic cough: P2X3 receptor antagonists and beyond. Pharmacol Ther. 2022;237:108166.
24. Wallace DV. Evaluation and management of chronic cough in adults. Allergy Asthma Proc. 2023;44(6):382-394.
26. Blaiss MS. Innovations in the treatment and management of chronic cough: expert perspectives on the role of new and emerging therapies. J Manag Care Med. 2023;26(4):12-17.
27. Nguyen AM, Schelfhout J, Muccino D, et al. Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough. Ther Adv Respir Dis. 2022:16:1-13.
28. Morice A, Dicpinigaitis P, McGarvey L, Birring SS. Chronic cough: new insights and future prospects. Eur Respir Rev. 2021;30(162):210127.
29. Kum E, Guyatt GH, Munoz C, et al. Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel. ERJ Open Res. 2022;8(1):00667-2021.
30. Irwin RS, Madison JM. Gefapixant for refractory or unexplained chronic cough? JAMA. 2023;330(14):1335-1336.
32. Shields JB, Callen E, Loskutova NY, Schelfhout J, Hester CM. Chronic cough diagnosis, treatment, and referral practices among family physicians in the United States: a survey study. BMC Prim Care. 2024;25(1):181.
33. Drake MG, McGarvey LP, Morice AH. From bench to bedside: the role of cough hypersensitivity in chronic cough. Clin Transl Med. 2023;13(8):e1343.
34. Yang X, Chung KF, Huang K. Worldwide prevalence, risk factors and burden of chronic cough in the general population: a narrative review. J Thorac Dis. 2023;15(4):2300-2313.
35. Kang MG, Song WJ, Kim HJ, et al. Point prevalence and epidemiological characteristics of chronic cough in the general adult population: the Korean national health and nutrition examination survey 2010–2012. Medicine (Baltimore). 2017;96(13):e6486.
36. van Boemmel-Wegmann S, Altman KW, Herrera R, Vieira Pires P, Pichardo PFA, Vora P. Characteristics of adults with potential refractory chronic cough identified using an algorithm designed for administrative claims databases: a descriptive study. Sci Prog. 2024;107(1):1-15.
37. Zeiger RS, Schatz M, Butler RK, Weaver JP, Bali V, Chen W. Burden of specialist-diagnosed chronic cough in adults. J Allergy Clin Immunol Pract. 2020;8(5):1645-1657.e7.
38. Zeiger RS, Schatz M, Hong B, et al. Patient-reported burden of chronic cough in a managed care organization. J Allergy Clin Immunol Pract. 2021;9(4):1624-1637.
41. Dicpinigaitis PV, Allusson VR, Baldanti A, Nalamati JR. Ethnic and gender differences in cough reflex sensitivity. Respiration. 2001;68(5):480-482.
42. Zhang J, Perret JL, Chang AB, et al. Risk factors for chronic cough in adults: a systematic review and meta-analysis. Respirology. 2022;27(1):36-47.
43. Mai Y, Zhan C, Zhang S, et al. Arnold nerve reflex: vagal hypersensitivity in chronic cough with various causes. Chest. 2020;158(1):264-271.
44. Weinberger SE, Saukkonen K. Evaluation and Treatment of Subacute and Chronic Cough in Adults. Available at https://www.uptodate.com/contents/evaluation-and-treatment-of-subacute-and-chronic-cough-in-adults. Last accessed July 29, 2024.
45. Irwin RS, Dudiki N, French CL, CHEST Expert Cough Panel. Life-threatening and non-life-threatening complications associated with coughing: a scoping review. Chest. 2020;158(5):2058-2073.
46. 46. Alhatemi AQM, Hashim HT, Hashim AT. Rib fracture secondary to cough-induced trauma. Clin Case Rep. 2024;12(5):e8823.
47. Dicpinigaitis PV. Prevalence of stress urinary incontinence in women presenting for evaluation of chronic cough. ERJ Open Res. 2021;7(1):2012-2021.
49. Everett CF, Kastelik JA, Thompson RH, Morice AH. Chronic persistent cough in the community: a questionnaire survey. Cough. 2007:3:5.
50. García-Vicente P, Rodríguez-Valiente A, Górriz Gil C, et al. Chronic cough in post-COVID syndrome: laryngeal electromyography findings in vagus nerve neuropathy. PLoS One. 2023;18(3):e0283758.
51. 51. Chamberlain SAF, Garrod R, Douiri A, et al. The impact of chronic cough: a cross-sectional European survey. Lung. 2015;193(3):401-408.
52. Yousaf N, Montinero W, Birring SS, Pavord ID. The long term outcome of patients with unexplained chronic cough. Respir Med. 2013;107(3):408-412.
53. Abozid H, Kirby M, Nasir N, et al. CT airway remodelling and chronic cough. BMJ Open Respir Res. 2023;10(1):e001462.
54. Deng SJ, Wang J, Liu L, et al. Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes. Allergy Asthma Proc. 2022;43(3):209-219.
55. Beech A, Portacci A, Herrero-Cortina B, et al. ERS International Congress 2022: highlights from the Airway Diseases Assembly. ERJ Open Res. 2023;9(3):00034-2023.
56. 56. Wicaksono MBA, Yunus F. Diagnosis and management of cough-variant asthma. Pneumologia. 2021;70:111-116.
57. Dicpinigaitis PV, Altman KW, Isci IU, Ke X, Blaiss M. Interdisciplinary collaboration in the diagnosis and management of chronic cough: the role and importance of primary care providers. Curr Med Res Opin. 2023;39(10):1375-1381.
58. Sykes DL, Morice AH. The cough reflex: the Janus of respiratory medicine. Front Physiol. 2021;12:684080.
59. Zhang M, Morice AH. Unravelling vagal hypersensitivity in chronic cough: a distinct disease. J Physiol. 2023; [Epub ahead of print].
60. Kornfield J, De La Torre U, Mize E, Drake MG. Illuminating airway nerve structure and function in chronic cough. Lung. 2023;201(6):499-509.
61. 61. Farooqi MAM, Cheng V, Wahab M, Shahid I, O'Byrne PM, Satia I. Investigations and management of chronic cough: a 2020 update from the European Respiratory Society Chronic Cough Task Force. Pol Arch Intern Med. 2020;130(9):789-795.
63. Smith JA, Satia I, Badri H, Marsden P. Mini-review: hypertussivity and allotussivity in chronic cough endotypes. Neurosci Lett. 2023;792:136934.
64. Mazzone S, Chung KF, McGarvey L. The heterogeneity of chronic cough: a case for endotypes of cough hypersensitivity. Lancet Respir Med. 2018;6(8):636-646.
65. Tamasauskiene L, Sitkauskiene B. Immune system in the pathogenesis of chronic cough. Immunol Lett. 2020;218:40-43.
66. 66. Turner RD, Hirons B, Cortese A, Birring SS. Chronic cough as a genetic neurological disorder? Insights from cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Lung. 2023;201(6):511-519.
67. Ando A, Smallwood D, McMahon M, Irving L, Mazzone SB, Farrell MJ. Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control. Thorax. 2016;71(4):323-329.
68. Moe AAK, Singh N, Dimmock M, et al. Brainstem processing of cough sensory inputs in chronic cough hypersensitivity. EBioMedicine. 2024:100:104976.
69. Smith JA, West PW. Branching out in chronic cough: evidence for increased airway nerve density. Am J Respir Crit Care Med. 2021;203(3):283-284.
70. Dockry RJ, Farrelly CL, Mitchell J, Corfield DR, Smith JA. Chronic cough is associated with increased reporting of autonomic symptoms. ERJ Open Res. 2021;7(3):00105-2021.
71. 71. Mazzone SB. Chronic cough: a disorder of response inhibition? Eur Respir J. 2019;53(5):1900254.
72. Namgung E, Song W-J, Kim Y-H, An J, Cho YS, Kang D-W. Structural and functional correlates of higher cortical brain regions in chronic refractory cough. Chest. 2022;162(4):851-860.
73. Diab N, Patel M, O'Byrne P, Satia I. Narrative review of the mechanisms and treatment of cough in asthma, cough variant asthma, and non-asthmatic eosinophilic bronchitis. Lung. 2022;200(6):707-716.
74. Sundar KM, Stark AC, Hu N, Barkmeier-Kraemer J. Is laryngeal hypersensitivity the basis for unexplained or refractory chronic cough? ERJ Open Res. 2021;7(1):00793-2020.
75. Demirjian NL, Lever A, Yip H. Identifying practice gaps among otolaryngology providers for the treatment of chronic cough. OTO Open. 2024;8(2):e143.
76. 76. Al-Hajjaj MS. Tips and pitfalls in the diagnosis and treatment of bronchial asthma. Advances in Biomedical and Health Sciences. 2023;2(2):58-61.
77. Ryan NM, Vertigan AE, Birring SS. An update and systematic review on drug therapies for the treatment of refractory chronic cough. Expert Opin Pharmacother. 2018;19(7):687-711.
78. Kukiełka P, Moliszewska K, Białek-Gosk K, Grabczak EM, Dąbrowska M. Prevalence of refractory and unexplained chronic cough in adults treated in cough centre. ERJ Open Res. 2024;10(4).
79. Morice A. A survey of UK respiratory specialists' opinion on the management of chronic cough. ERJ Open Res. 2024;10(4).
80. Irwin RS, Rosen MJ, Braman SS. Cough. A comprehensive review. Arch Intern Med. 1977;137(9):1186-1191.
81. Irwin RS, Boulet LP, Cloutier MM, et al. Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest. 1998;114(2 Suppl Managing):133S-181S.
82. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):1S-23S.
83. Kahrilas PJ, Altman KW, Chang AB, et al. Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report. Chest. 2016;150(6):1341-1360.
84. Côté A, Russell RJ, Boulet LP, et al. Managing chronic cough due to asthma and NAEB in adults and adolescents: CHEST guideline and expert panel report. Chest. 2020;158(1):68-96.
85. Malesker MA, Callahan-Lyon P, Madison JM, Ireland B, Irwin RS, CHEST Expert Cough Panel. Chronic cough due to stable chronic bronchitis: CHEST Expert Panel Report. Chest. 2020;158(2):705-718.
86. Gibson P, Wang G, McGarvey L, et al. Treatment of unexplained chronic cough: CHEST guideline and expert panel report. Chest. 2016;149(1):27-44.
87. Agustí A, Rapsomaniki E, Beasley R, et al. Treatable traits in the NOVELTY study. Respirology. 2022;27(11):929-940.
88. Zhang Q, Wu WW, Li L, et al. Workup of difficult-to-treat asthma: implications from treatable traits. Precis Clin Med. 2023;6(1):pbad003.
89. McDonald VM, Hamada Y, Agusti A, Gibson PG. Treatable traits in asthma: the importance of extrapulmonary traits: GERD, CRSwNP, atopic dermatitis, and depression/anxiety. J Allergy Clin Immunol Pract. 2024;12(4):824-837.
90. 90. Morice AH, Fontana GA, Sovijarvi ARA, et al. The diagnosis and management of chronic cough. Eur Respir J. 2004;24:481-492.
91. Jutel M, Agache I, Zemelka-Wiacek M, et al. Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper. Allergy. 2023;78(11):2851-2874.
92. Rank MA, Chu DK, Bognanni A, et al. The joint task force on practice parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2023;151(2):386-398.
93. Toppila-Salmi S, Bjermer L, Cardell L-O, et al. Multi-disciplinary expert perspective on the management of type 2 inflammation-driven severe CRSwNP: a brief overview of pathophysiology and recent clinical insights. J Asthma Allergy. 2024;17:431-439.
94. Jiang Y, An R, Cheng L, et al. Classification of non-acute bronchial asthma according to allergy and eosinophil characteristics: a retrospective study. Allergy Asthma Clin Immunol. 2021;17(1):45.
95. 95. Marra AM, Rossi CM, Piga MA, Moroncini G, Bilò MB. Eosinophil-associated diseases: the allergist's and clinical immunologist's perspective. Eur Ann Allergy Clin Immunol. 2024;[Epub ahead of print].
96. Kalchiem-Dekel O, Yao X, Levine SJ. Meeting the challenge of identifying new treatments for type 2-low neutrophilic asthma. Chest. 2020;157(1):26-33.
97. Jin FD, Wang J, Deng SJ, et al. Interaction effect of chronic cough and ageing on increased risk of exacerbation in patients with asthma: a prospective cohort study in a real-world setting. ERJ Open Res. 2023;9(6):00461-2023.
98. Sun J, Zhan C, Deng Z, et al. Expression of interferon-γand its effect on cough hypersensitivity in chronic refractory cough patients. Thorax. 2022;77(6):621-624.
99. Dicpinigaitis PV. Chronic cough and refractory chronic cough: an important distinction. J Precis Respir Med. 2023;6(1):10-13.
100. Irwin RS, French CL, Chang AB, Altman KW, CHEST Expert Cough Panel. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153(1):196-209.
102. Song DJ, Song WJ, Kwon JW, et al. KAAACI evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res. 2018;10(6):591-613.
103. National Institute for Health and Care Excellence. Asthma: Diagnosis, Monitoring and Chronic Asthma Management. Available at http://www.nice.org.uk/guidance/ng80. Last accessed July 26, 2024.
104. Rouadi PW, Idriss SA, Bousquet J, et al. WAO-ARIA consensus on chronic cough. Part III: management strategies in primary and cough-specialty care: updates in COVID-19. World Allergy Organ J. 2022;15(5):100649.
105. 105. Ambrosino P, Accardo M, Mosella M, et al. Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis. Ann Med. 2021;53(1):1659-1672.
106. Lee JH, Kang S-Y, Yu I, et al. Cough response to high-dose inhaled corticosteroids in patients with chronic cough and fractional exhaled nitric oxide levels ≥ 25 ppb: a prospective study. Lung. 2024;202(3):275-280.
107. Fukumitsu K, Kanemitsu Y, Asano T, et al. Tiotropium attenuates refractory cough and capsaicin cough reflex sensitivity in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(5):1613-1620.
108. Fukumitsu K, Kanemitsu Y, Kurokawa R, et al. Tiotropium for refractory cough in asthma via cough reflex sensitivity: a randomized, parallel, open-label trial. Ann Allergy Asthma Immunol. 2023;131(1):59-68.
109. Weinberger SE, Saukkonen K. Causes and Epidemiology of Subacute and Chronic Cough in Adults. Available at https://www.uptodate.com/contents/causes-and-epidemiology-of-subacute-and-chronic-cough-in-adults. Last accessed July 29, 2024.
110. Papi A, Faner R, Pavord I, et al. From treatable traits to GETomics in airway disease: moving towards clinical practice. Eur Respir Rev. 2024;33(171):230143.
111. Hirons B, Rhatigan K, Kesavan H, Turner RD, Birring SS, Cho PSP. Cough in chronic lung disease: a state of the art review. J Thorac Dis. 2023;15(10):5823-5843.
112. Lai K, Satia I, Song W-J, et al. Cough and cough hypersensitivity as treatable traits of asthma. Lancet Respir Med. 2023;11(7):650-662.
113. Ortega VE, Izquierdo M. Asthma. Available at https://www.merckmanuals.com/professional/pulmonary-disorders/asthma-and-related-disorders/asthma. Last accessed July 26, 2024.
114. Maspero J, Adir Y, Al-Ahmad M, et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022;8(3):00576-2021.
115. Kim M-Y, Won H-K, Oh J-Y, et al. Could cough hypersensitivity symptom profile differentiate phenotypes of chronic cough? ERJ Open Res. 2024;10(4).
116. Villalobos-Violan V, Betancor D, Mahíllo-Fernández I, Sastre J. Nonasthmatic eosinophilic bronchitis and asthma: analysis of biomarkers. J Investig Allergol Clin Immunol. 2022;32(3):216-217.
117. Michaudet C, Malaty J. Chronic cough: evaluation and management. Am Fam Physician. 2017;96(9):575-580.
118. Gonlugur U, Gonlugur TE. Eosinophilic bronchitis without asthma. Int Arch Allergy Immunol. 2008;147(1):1-5.
119. World Health Organization. ICD-11 for Mortality and Morbidity Statistics 2024-01. Available at https://icd.who.int/browse/2024-01/mms/en. Last accessed July 29, 2024.
120. 120. Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900651.
121. Liu Y, Carlson SA, Watson KB, Xu F, Greenlund KJ. Trends in the prevalence of chronic obstructive pulmonary disease among adults aged ≥18 years—United States, 2011–2021. MMWR. 2023;72(46):1250-1256.
122. Syamlal G, Kurth LM, Dodd KE, Blackley DJ, Hall NB, Mazurek JM. Chronic obstructive pulmonary disease mortality by industry and occupation—United States, 2020. MMWR. 2022;71(49):1550-1554.
123. Wise RA. Chronic Obstructive Pulmonary Disease (COPD). Available at https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/chronic-obstructive-pulmonary-disease-copd. Last accessed July 29, 2024.
125. Wu Z, Banya W, Chaudhuri N, et al. PAciFy cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary fibrosis cough. Trials. 2022;23:184.
126. Lee J, White E, Freiheit E, et al. Cough-specific quality of life predicts disease progression among patients with interstitial lung disease: data from the Pulmonary Fibrosis Foundation patient registry. Chest. 2022;162(3):603-613.
127. Dąbrowska M, Arcimowicz M, Grabczak EM, et al. Chronic cough related to the upper airway cough syndrome: one entity but not always the same. Eur Arch Otorhinolaryngol. 2020;277(10):2753-2759.
128. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020;146(4):721-767.
129. Baroody FM, Gevaert P, Smith PK, Ziaie N, Bernstein JA. Nonallergic rhinopathy: a comprehensive review of classification, diagnosis, and treatment. J Allergy Clin Immunol Pract. 2024:12(6):1436-1447.
130. 130. Battisti AS, Modi P, Pangia J. Sinusitis. Treasure Island, FL: StatPearls Publishing; 2023.
131. Zhao P, Kariya S, Higak T, et al. Chronic rhinosinusitis possibly associated with decreased lung function in chronic cough patients. Braz J Otorhinolaryngol. 2024;90(4):101424.
133. Gyawali CP, Yadlapati R, Fass R, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024;73(2):361-371.
134. Chen JW, Vela MF, Peterson KA, Carlson DA. AGA clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease: expert review. Clin Gastroenterol Hepatol. 2023;21(6):1414-1421.
135. 135. Decalmer S, Stovold R, Houghton LA, et al. Chronic cough: relationship between microaspiration, gastroesophageal reflux, and cough frequency. Chest. 2012;142(4):958-964.
136. Zhang L, Zhang M, Aierken A, Dong R, Chen Q, Qiu Z. Role of alveolar nitric oxide in gastroesophageal reflux-associated cough: prospective observational study. Ther Adv Respir Dis. 2024;18:1-16.
137. Hránková V, Balner T, Gubová P, Staníková L, Zeleník K, Komínek P. Narrative review of relationship between chronic cough and laryngopharyngeal reflux. Front Med (Lausanne). 2024:11:1348985.
138. Pérez-Pazos J, García-Sánchez A, Estravís M, et al. Beyond T2-asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease. ERJ Open Res. 2024;10(4).
139. Lai K, Tang J, Zhan W, et al. The spectrum, clinical features and diagnosis of chronic cough due to rare causes. J Thorac Dis. 2021;13(4):2575-2582.
140. 140. Wingfield Digby J, King J, Al-Sheklly B, Marsden P, Fowler S, Smith J. Bronchoscopy for refractory/unexplained cough with mucus. Respir Med. 2023;217:107335.
141. Levy ML, Bacharier LB, Bateman E, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim Care Respir Med. 2023;33(1):7.
142. Global Initiative for Asthma. 2024 GINA Main Report: Global Strategy for Asthma Management and Prevention. Available at https://ginasthma.org/2024-report/. Last accessed July 25, 2024.
143. King J, Al-Sheklly B, Wingfield Digby J, et al. Refractory chronic cough patients are indiscriminately hyper-responsive to inhaled tussive irritants/agents. Am J Respir Crit Care Med. 2022;205:A2809.
144. Ryan MA, Cohen SM. Long-term follow-up of amitriptyline treatment for idiopathic cough. Laryngoscope. 2016;126(12):2758-2763.
145. Peechakara BV, Tharp JG, Eriator II, Gupta M. Codeine. Treasure Island, FL: StatPearls Publishing; 2023.
146. Song W-J, Chung KF. Pharmacotherapeutic options for chronic refractory cough. Expert Opin Pharmacother. 2020;21(11):1345-1358.
147. Morice AH, Menon MS, Mulrennan SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007;175(4):312315.
148. Al-Sheklly B, Mitchell J, Issa B, et al. S35 Randomised control trial quantifying the efficacy of low dose morphine in a responder group of patients with refractory chronic cough. Thorax. 2017;72(Suppl 3):A24-A25.
149. Mitchell J, Al-Sheklly B, Issa B, et al. P104 Sensations associated with experimentally evoked cough: influence of low dose morphine sulphate in opioid responders. Thorax. 2017;72(Suppl 3):A139-A140.
150. King J, Wingfield-Digby J, Hennessey S, et al. Real world effectiveness and tolerability of low-dose opiates for refractory/unexplained chronic cough (RCC/UCC) in a tertiary clinic. Eur Respir J. 2022;60(Suppl 66):1159.
151. Zhang M, Zhu Y, Dong R, Qiu Z. Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough. J Thorac Dis. 2020;12(9):5243-5250.
152. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9853):1583-1589.
153. Saint-Pierre MD. Predictors of treatment response to pregabalin in unexplained or refractory chronic cough. Respir Med. 2023:218:107396.
154. Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest. 2016;149(3):639-648.
155. Al-Sheklly B, Badri H, Satia I, Woodcock A, Smith JA. P106 The use of gabapentin and pregabalin for the management of chronic cough in a tertiary cough clinic. Thorax. 2017;72(Suppl 3):A140-A142.
156. Dicpinigaitis PV, Morice AH, Birring SS, et al. Antitussive drugs: past, present, and future. Pharmacol Rev. 2014;66(2):468-512.
157. Jeyakumar A, Brickman TM, Haben M. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope. 2006;116(12):2108-2112.
158. Jang M, Rubin SJ, Stein DJ, Noordzij JP. Randomized double blind trial of amitriptyline versus placebo in treatment of chronic laryngopharyngeal neuropathy. Am J Otolaryngol. 2017;38(6):683-687.
159. Song SA, Choksawad K, Franco RA Jr. The effectiveness of nortriptyline and tolerability of side effects in neurogenic cough patients. Ann Otol Rhinol Laryngol. 2021;130(7):781-787.
160. Lečić SK, Javorac J, Živanović D, et al. Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review. Ups J Med Sci. 2022;127:e8739.
161. Wu Z, Spencer LG, Banya W, et al. Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial. Lancet Respir Med. 2024;12(4):P273-P280.
162. Maher TM, Avram C, Bortey E, et al. Nalbuphine tablets for cough in patients with idiopathic pulmonary fibrosis. NEJM Evid. 2023;2(8):EVIDoa2300083.
163. Fabbri L, Guiot J, Vermant M, et al. ERS International Congress 2023: highlights from the Interstitial Lung Diseases Assembly. ERJ Open Res. 2024;10(2):00839-2023.
164. Domnik NJ, Yaggi HK. Lessons about low-dose morphine at the intersection of sleep and breathlessness. Am J Respir Crit Care Med. 2024; [Epub ahead of print].
165. Pelleg A, Sirtori E, Rolland J-F, Mahadevan A. DT-0111: a novel P2X3 receptor antagonist. Purinergic Signal. 2023;19(3):467-479.
166. Morice AH, Kitt MM, Ford AP, et al. The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study. Eur Respir J. 2019;54(1):1900439.
167. Abdulqawi R, Dockry R, Holt K, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet. 2015;385(9974):1198-1205.
168. Iyer VN, Dicpinigaitis P, Taliercio R, et al. Camlipixant reduces burden of cough-related urinary incontinence in patients with refractory chronic cough in post-hoc analysis of a phase 2b trial. Am J Respir Crit Care Med. 2024;209:A7083.
169. Abdulqawi R, Satia I, Kanemitsu Y, et al. A randomized controlled trial to assess the effect of lidocaine administered via throat spray and nebulization in patients with refractory chronic cough. J Allergy Clin Immunol Pract. 2021;9(4):1640-1647.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.